Cargando…

Survival and HLA-B*57 in HIV/HCV Co-Infected Patients on Highly Active Antiretroviral Therapy (HAART)

BACKGROUND AND AIMS: HLA class I alleles, in particular HLA-B*57, constitute the most consistent host factor determining outcomes in untreated HCV- and HIV-infection. In this prospective cohort study, we analysed the impact of HLA class I alleles on all-cause mortality in patients with HIV-, HCV- an...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dold, Leona, Ahlenstiel, Golo, Althausen, Eva, Luda, Carolin, Schwarze-Zander, Carolynne, Boesecke, Christoph, Wasmuth, Jan-Christian, Rockstroh, Jürgen Kurt, Spengler, Ulrich
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4524598/ https://www.ncbi.nlm.nih.gov/pubmed/26241854 http://dx.doi.org/10.1371/journal.pone.0134158

Ejemplares similares

Genetic polymorphisms associated with fatty liver disease and fibrosis in HIV positive patients receiving combined antiretroviral therapy (cART)
por: Dold, Leona, et al.
Publicado: (2017)

Return-to-health effect of modern combined antiretroviral therapy potentially predisposes HIV patients to hepatic steatosis
por: Mohr, Raphael, et al.
Publicado: (2018)

Stratifying the risk of NAFLD in patients with HIV under combination antiretroviral therapy (cART)
por: Bischoff, Jenny, et al.
Publicado: (2021)

Survival of HIV/HCV co-infected patients before introduction of HCV direct acting antivirals (DAA)
por: Dold, L., et al.
Publicado: (2019)

TLR agonists enhance responsiveness of inflammatory innate immune cells in HLA-B*57-positive HIV patients
por: Dold, L., et al.
Publicado: (2020)

Liver Fibrosis in HIV Patients Receiving a Modern cART: Which Factors Play a Role?
por: Mohr, Raphael, et al.
Publicado: (2015)

Circulating levels of endotrophin and cross-linked type III collagen reflect liver fibrosis in people with HIV
por: Dold, Leona, et al.
Publicado: (2023)

Exposure to previous cART is associated with significant liver fibrosis and cirrhosis in human immunodeficiency virus-infected patients
por: Anadol, Evrim, et al.
Publicado: (2018)

Circulating levels of PRO-C3 reflect liver fibrosis and liver function in HIV positive patients receiving modern cART
por: Dold, Leona, et al.
Publicado: (2019)

Implementation of EACS vaccination recommendations among people living with HIV
por: Breitschwerdt, Sven, et al.
Publicado: (2022)

Alterations of the NK cell pool in HIV/HCV co-infection
por: Kaczmarek, Dominik J., et al.
Publicado: (2017)

Moderate endurance training (marathon-training) – effects on immunologic and metabolic parameters in HIV-infected patients: the 42 KM cologne project
por: Schlabe, Stefan, et al.
Publicado: (2017)

Cancer risk in HIV-infected individuals on HAART is largely attributed to oncogenic infections and state of immunocompetence
por: Vogel, M, et al.
Publicado: (2011)

Impact of COVID‐19 on HIV late diagnosis in a specialized German centre
por: van Bremen, Kathrin, et al.
Publicado: (2022)

The Natural Killer Cell Response to HCV Infection
por: Ahlenstiel, Golo
Publicado: (2013)

SARS-CoV-2 seroconversions and chains of infection in healthcare professionals in a German maximum care provider (The CoSHeP study)
por: van Bremen, Kathrin, et al.
Publicado: (2021)

The influence of HAART on the efficacy and safety of pegylated interferon and ribavirin therapy for the treatment of chronic HCV infection in HIV-positive individuals
por: Vogel, M, et al.
Publicado: (2010)

HPV-associated anal lesions in HIV+ patients: long-term results regarding quality of life
por: Wesselmann, Paul, et al.
Publicado: (2020)

Transient elastography discloses identical distribution of liver fibrosis in chronic hepatitis C between HIV-negative and HIV-positive patients on HAART
por: Grünhage, F, et al.
Publicado: (2010)

microRNA‐200a: A stage‐dependent biomarker and predictor of steatosis and liver cell injury in human immunodeficiency virus patients
por: Austermann, Christian, et al.
Publicado: (2017)

Circulating MiRNA-122 Levels Are Associated with Hepatic Necroinflammation and Portal Hypertension in HIV/HCV Coinfection
por: Jansen, Christian, et al.
Publicado: (2015)

Compartment-specific distribution of human intestinal innate lymphoid cells is altered in HIV patients under effective therapy
por: Krämer, Benjamin, et al.
Publicado: (2017)

Rabies post-exposure prophylaxis in Germany − What are the challenges?
por: Meyerhoff, P., et al.
Publicado: (2021)

Immunomodulation of the Natural Killer Cell Phenotype and Response during HCV Infection
por: Njiomegnie, Gaitan Fabrice, et al.
Publicado: (2020)

Tolerability of antiretroviral therapy (HAART) in elderly age
por: Celesia, B M
Publicado: (2010)

HCV cure for everyone or which challenges remain?
por: Rockstroh, Jürgen Kurt
Publicado: (2015)

Transmission of Human Immunodeficiency Virus I Drug Resistance - a Case Report. What are the Clinical Implications?
por: Anadol, E, et al.
Publicado: (2010)

Ophthalmic manifestations of human immunodeficiency virus infection: Pre- highly active antiretroviral chemotherapy (HAART) and post- HAART era
por: Sinha, Rajesh, et al.
Publicado: (2008)

Distinct antibody profiles in HLA-B(∗)57(+), HLA-B(∗)57(−) HIV controllers and chronic progressors
por: Klingler, Jéromine, et al.
Publicado: (2022)

The Role of Zinc in Antiviral Immunity
por: Read, Scott A, et al.
Publicado: (2019)

HLA-B(*)57 Allele Is Associated with Concomitant Anti-tuberculosis and Antiretroviral Drugs Induced Liver Toxicity in Ethiopians
por: Petros, Zelalem, et al.
Publicado: (2017)

Prevalence of Hypertension in HIV/AIDS Patients on Highly Active Antiretroviral Therapy (HAART) Compared with HAART-Naïve Patients at the Limbe Regional Hospital, Cameroon
por: Dimala, Christian Akem, et al.
Publicado: (2016)

Managing HCV infection: present and future
por: Rockstroh, Jürgen K
Publicado: (2014)

Clinically Significant Lower Elvitegravir Exposure During the Third Trimester of Pregnant Patients Living With Human Immunodeficiency Virus: Data From the Pharmacokinetics of ANtiretroviral agents in HIV-infected pregNAnt women (PANNA) Network
por: Bukkems, Vera, et al.
Publicado: (2020)

Tissue viral dynamics in SIV infected macaques with highly active antiretroviral therapy (HAART)
por: Bourry, Olivier, et al.
Publicado: (2009)

Modification of Initial Highly Active Antiretroviral Therapy (HAART) Regimen in Paediatric HIV Patients
por: Low, Yee Shan, et al.
Publicado: (2018)

The Potential of Spirulina platensis to Ameliorate the Adverse Effects of Highly Active Antiretroviral Therapy (HAART)
por: Sibiya, Thabani, et al.
Publicado: (2022)

Reprogramming—Evolving Path to Functional Surrogate β-Cells
por: Kalo, Eric, et al.
Publicado: (2022)

Hepatic steatosis in HIV-HCV coinfected patients receiving antiretroviral therapy is associated with HCV-related factors but not antiretrovirals
por: Martinez, Valrie, et al.
Publicado: (2012)

Hepatic steatosis in HIV-HCV coinfected patients receiving antiretroviral therapy is associated with HCV-related factors but not antiretrovirals
por: Martinez, Valérie, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_eba8b6ok5svpcb3u62deoed1nr